Scott Morrison

  There have been increased levels of competition in the pharmaceutical industry, especially within the cardiac and diabetic sector where there is a steady increase in the need for good medicines. Branding has become an important aspect of doing business in order to stand out amongst competitors who are entering into this line of work. In the case of Cardiac Diabetic PCD companies, branding is very important since it aids in building trust and market recognition, and in attracting franchises. Why is Branding Important for Cardiac Diabetic PCD Companies? Branding refers to the creation of a unique identity which makes one company different from its competitors. For the pharmaceutical industry, branding encompasses the reputation of the company, packaging of the products, promotional items, customer service, and general market presence. Benefits of Branding to cardiac diabetic PCD companies: Builds credibility in the healthcare market Improves product awareness Attracts and retains f...

India’s pharmaceutical industry is growing at a tremendous rate, and among them the most lucrative one is the cardiac diabetic pharma franchise sector . Due to the increase in the number of lifestyle disorders like diabetes, hypertension, and cardiac diseases, the demand for specialised drugs is also increasing. This provides a golden opportunity for entrepreneurs, medical representatives, distributors, and healthcare professionals who are looking to establish a successful pharmaceutical venture . Growing Demand for Cardiac and Diabetic Medicines India has earned the nickname ‘diabetes capital of the world’, as there are millions of people who need drugs on a constant basis for their treatment. Likewise, cardiovascular diseases have remained the main reasons for deaths in India. It is because of this reason that healthcare facilities are always looking out for trustworthy pharmaceutical firms that can provide heart and diabetes drugs. The increasing number of patients in such categorie...

The Cardio-Diabetic and Chronic Health Disorders keep moving into the new paradigm. One of the world’s most serious Chronic Health Disorders, Cardio-diabetic is on its new journey as the Pharmaceutical Industry comes into the light by delivering the next-generation solutions and medicines and it is all going to change for good to transform the lives of patients, managing their Chronic Health Disorders. Medical practitioners are seeing and embracing a completely different kind of Cardiac and Diabetic Pharmaceutical Solution which goes all out to take proper care of these inter-connected Chronic Health Disorders. Today’s most advanced diabetic medicines, DPP-4 inhibitors and SGLT2 inhibitors have proven themselves not just for managing blood glucose but for managing the very core of your heart as well – your life will change in a big way with the availability of these. These not just control and maintain blood sugar but do so by helping you avoid and lower your risk of experiencing heart...

There is a substantial transformation occurring in the Indian Pharmaceutical market which has two therapy segments as a stronger growth engine-Cardiac and anti-diabetic medicines. Driven by rapid changes in disease burden, urbanization and lifestyle, demand for these drugs will never fall flat. The Scale of the Problem The figures are astonishing, cardiovascular diseases cause 28% of all deaths in India as reported by WHO whereas more than 80 million Indians are currently suffering from diabetes and it is estimated to be more than 98 million in 2025. INDIAB report by the Indian Council of Medical Research claims there are 101 million Indians suffering from diabetes and the risk factors are urbanisation, age, obesity, poor diet and genetic factor.  The dual epidemics lead to persistent growing demand in both the therapy segments. The TribuneInternational Journal of Pharmaceutical Sciences Market Size and Growth Trajectory The figures indicate robust commercial demand. India's diabet...

Cardiac and diabetic drugs are not purchases that are made from time to time, but in fact become an integral part of a patients routine and often last lifetime. This one simple factor changes the entire dynamics of how such products reach a patient.  A missed refill appointment in this case may not just mean a lost opportunity but an emergency situation. The network for such products therefore needs more rigor, reach, reliability than probably any other pharmaceutical segment. Start with Therapy-Specific Demand Mapping Cardiovascular and diabetes patients’ densities differ widely across geographic regions, demographics, lifestyle factors. Before appointing C&F agents or distributors for new territories, map out existing prescriptions, footfall of hospitals in the area, and incidence rates of chronic diseases. This will ensure that the inventory is stocked where sustained demand actually exists, rather than thinly distributed across markets that have low sustained need. Choose D...

There has been impressive growth in the pharmaceutical sector of India, particularly within specific sectors like cardiac and diabetic treatments. Due to an increase in heart-related diseases, high blood pressure, and diabetes, the need for good quality drugs increases. This has led to an influx of individuals into the Cardiac Diabetic PCD Franchise business . But for one to be successful in this highly competitive industry, marketing has to be incorporated in the business. There is a role of marketing support in assisting the franchise partners in establishing themselves and building up their reputation among healthcare practitioners and other customers. When there is enough marketing help available from a firm, it enables its franchises to concentrate on business development. Why Marketing Support Matters in a Cardiac Diabetic PCD Franchise? The cardiac and diabetes niche requires high specialisation in trust, product knowledge, and interaction with doctors, chemists, and health pra...